International Flavors & F... (IFF)
NYSE: IFF
· Real-Time Price · USD
77.54
0.88 (1.15%)
At close: Jun 04, 2025, 3:59 PM
77.47
-0.09%
After-hours: Jun 04, 2025, 04:00 PM EDT
International Flavors & Fragrances Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|
| Nourish Revenue | 5.87B | 6.06B | 6.83B | 6.26B |
| Nourish Revenue Growth | -3.12% | -11.26% | +9.02% | n/a |
| Pharma Solutions Revenue | 961M | 945M | 971M | 809M |
| Pharma Solutions Revenue Growth | +1.69% | -2.68% | +20.02% | n/a |
| Scent Revenue | 2.44B | 2.39B | 2.3B | 2.25B |
| Scent Revenue Growth | +1.96% | +4.00% | +2.09% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States Revenue | 3.22B | 2.68B | 2.88B | 2.73B | 1.09B | 1.05B | 991.01M | 903.55M | 880.04M | 839.12M | 1.04B | 971.92M | 912.77M |
| United States Revenue Growth | +20.25% | -6.92% | +5.43% | +149.58% | +3.84% | +6.22% | +9.68% | +2.67% | +4.88% | -19.44% | +7.17% | +6.48% | n/a |
| Asia Revenue | 2.73B | 3.83B | 4.22B | 4.09B | 1.16B | 1.16B | 1.4B | 1.07B | 964.93M | 945.67M | 856.22M | 823.5M | 771.88M |
| Asia Revenue Growth | -28.77% | -9.13% | +3.08% | +252.34% | -0.11% | -16.71% | +31.04% | +10.43% | +2.04% | +10.45% | +3.97% | +6.69% | n/a |
| Emea Revenue | 3.84B | 1.49B | 1.49B | 1.34B | 1.99B | 2.08B | 580.08M | 527.76M | 502.3M | 519.78M | 500.52M | 476.63M | 442.37M |
| Emea Revenue Growth | +157.55% | -0.07% | +11.68% | -32.78% | -4.53% | +258.87% | +9.91% | +5.07% | -3.36% | +3.85% | +5.01% | +7.74% | n/a |
| Latin America Revenue | 1.47B | 3.48B | 3.85B | 3.5B | 706.94M | 724.84M | 1.01B | 901.82M | 769.08M | 718.61M | 690.21M | 680.84M | 694.43M |
| Latin America Revenue Growth | -57.64% | -9.76% | +10.12% | +394.95% | -2.47% | -28.24% | +12.01% | +17.26% | +7.02% | +4.11% | +1.38% | -1.96% | n/a |
| North America Revenue | 3.44B | n/a | n/a | n/a | 1.23B | 1.17B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| North America Revenue Growth | n/a | n/a | n/a | n/a | +4.93% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 461M | 517M | 495M | 403M | 432M | 444M | 444M | 445M | 454M | 440M | 413M | 456M | 459M | 450M | 436M | 412M | 451M | 254.19M | 234.52M | 230.41M | 229.71M | 242M | 210.83M | 210.1M | 213.18M | 249.61M | 157.8M | 157.41M | 142.64M | 139.6M | 141.47M | 135.91M | 140.33M | 157.85M | 152.05M | 132.78M | 123.54M | 137.53M | 127.66M | 134.06M | 120.83M |
| Selling, General, and Administrative Revenue Growth | -10.83% | +4.44% | +22.83% | -6.71% | -2.70% | 0.00% | -0.22% | -1.98% | +3.18% | +6.54% | -9.43% | -0.65% | +2.00% | +3.21% | +5.83% | -8.65% | +77.42% | +8.39% | +1.79% | +0.30% | -5.08% | +14.79% | +0.35% | -1.45% | -14.60% | +58.19% | +0.25% | +10.35% | +2.18% | -1.33% | +4.09% | -3.15% | -11.10% | +3.82% | +14.51% | +7.48% | -10.17% | +7.73% | -4.77% | +10.95% | n/a |
| Research and Development Revenue | 164M | 170M | 162M | 173M | 166M | 157M | 157M | 161M | 161M | 143M | 145M | 158M | 157M | 166M | 156M | 164M | 143M | 100.04M | 89.97M | 80.95M | 85.91M | 85.64M | 85.08M | 84.82M | 90.6M | 83.04M | 75.3M | 74.77M | 78.48M | 75.06M | 70.93M | 70.32M | 69.71M | 63.21M | 64.42M | 63.25M | 63.38M | 57.38M | 62.75M | 62.51M | 63.46M |
| Research and Development Revenue Growth | -3.53% | +4.94% | -6.36% | +4.22% | +5.73% | 0.00% | -2.48% | 0.00% | +12.59% | -1.38% | -8.23% | +0.64% | -5.42% | +6.41% | -4.88% | +14.69% | +42.95% | +11.19% | +11.14% | -5.77% | +0.32% | +0.66% | +0.31% | -6.38% | +9.10% | +10.27% | +0.72% | -4.73% | +4.55% | +5.82% | +0.87% | +0.87% | +10.28% | -1.87% | +1.84% | -0.21% | +10.47% | -8.56% | +0.38% | -1.49% | n/a |